Literature DB >> 8609336

Ergonovine echocardiography for coronary spasm: facts and wishful thinking.

C J Pepine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8609336     DOI： 10.1016/0735-1097(96)00015-0

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  6 in total

Review 1.  Provocative testing for coronary reactivity and spasm.

Authors:  Melody Zaya; Puja K Mehta; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2013-11-06       Impact factor: 24.094

2.  123I-MIBG myocardial scintigraphy as a noninvasive screen for the diagnosis of coronary artery spasm.

Authors:  J W Ha; J D Lee; Y Jang; N Chung; J Kwan; S J Rim; Y J Lee; W H Shim; S Y Cho; S S Kim
Journal:  J Nucl Cardiol       Date:  1998 Nov-Dec       Impact factor: 5.952

Review 3.  Prinzmetal angina: ECG changes and clinical considerations: a consensus paper.

Authors:  Antonio Bayés de Luna; Iwona Cygankiewicz; Adrian Baranchuk; Miquel Fiol; Yochai Birnbaum; Kjell Nikus; Diego Goldwasser; Javier Garcia-Niebla; Samuel Sclarovsky; Hein Wellens; Günter Breithardt
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-09       Impact factor: 1.468

4.  Ergonovine stress echocardiography: Recent experience and safety in our centre.

Authors:  Alejandro Cortell; Pedro Marcos-Alberca; Carlos Almería; José L Rodrigo; Leopoldo Pérez-Isla; Carlos Macaya; José Luis Zamorano
Journal:  World J Cardiol       Date:  2010-12-26

5.  Ergonovine Stress Echocardiography for the Diagnosis of Vasospastic Angina and Its Prognostic Implications in 3,094 Consecutive Patients.

Authors:  Yeo Jeong Song; Sang Jin Ha; Dong Seok Lee; Woo Dae Bang; Dong Geum Shin; Yeongmin Woo; Sangsig Cheong; Sang Yong Yoo
Journal:  Korean Circ J       Date:  2018-10       Impact factor: 3.243

6.  Verapamil and vasospastic angina: underuse in the elderly population.

Authors:  Xavier Humbert; Vincent Roule; Paul Milliez; Joachim Alexandre
Journal:  J Geriatr Cardiol       Date:  2017-07       Impact factor: 3.327
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.